Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Sezary Syndrome 2 Sarcoma, Ewing 1 Sarcoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

Doxorubicin 62 Ifosfamide 39 Gemcitabine 29 Radiotherapy 27 Filgrastim 27 Cyclophosphamide 26 Docetaxel 19 Vincristine 18 pembrolizumab 17 Etoposide 17 pazopanib 16 Cisplatin 16 Nivolumab 15 Trabectedin 14 apatinib 13 Magnetic Resonance Spectroscopy 13 Carboplatin 12 Irinotecan 11 Bevacizumab 11 Temozolomide 10 Sirolimus 10 camrelizumab 9 anlotinib 9 Surgical Procedures, Operative 9 Sorafenib 9 Paclitaxel 9 Ipilimumab 9 Injections 9 Dactinomycin 9 Topotecan 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma × Methoxsalen × Clear all

NCT03778996 2025-02-24

HopES

Sarcoma Oncology Research Center, LLC

Phase 2 Active not recruiting

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡